We are live on ! Find out more
SCP

Silverleafe Capital Partners Portfolio holdings

AUM $367M
1-Year Est. Return 37.49%
This Fund
S&P 500
This Quarter Est. Return
+0.63%
1 Year Est. Return
+37.49%
3 Year Est. Return
+82.76%
5 Year Est. Return
+101.4%
10 Year Est. Return
AUM
$337M
AUM Growth
+$10.4M
Cap. Flow
+$13.9M
Cap. Flow %
4.12%
Top 10 Hldgs %
55.87%
Holding
107
New
15
Increased
38
Reduced
23
Closed
9

Top Buys

Rank Stock Value
1
OKLO
Oklo
OKLO
+$2.5M
2
PLTR icon
Palantir
PLTR
+$1.51M
3
CORZ icon
Core Scientific
CORZ
+$1.27M
4
TEM
Tempus AI
TEM
+$1.24M
5
ARQT icon
Arcutis Biotherapeutics
ARQT
+$1.19M

Sector Composition

Rank Sector Weight
1 Technology 9.21%
2 Financials 8.43%
3 Industrials 7.34%
4 Consumer Staples 7.09%
5 Consumer Discretionary 4.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
101
Bristol-Myers Squibb
BMY
$130B
-20,318
Closed -$916K
BYRN icon
102
Byrna Technologies
BYRN
$106M
-9,769
Closed -$216K
CAG icon
103
Conagra Brands
CAG
$7.18B
-30,000
Closed -$549K
IFN
104
Aberdeen India Fund
IFN
$505M
-19,262
Closed -$282K
QQQM icon
105
PUT
Invesco NASDAQ 100 ETF
QQQM
$101B
-16,700
Closed -$3.05M
TGT icon
106
Target
TGT
$67.1B
-2,262
Closed -$203K
ETH
107
Grayscale Ethereum Staking Mini ETF Shares
ETH
$1.75B
-7,454
Closed -$292K

Similar funds

Silverleafe Capital Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Silverleafe Capital Partners held 107 positions worth $337M, up 3.2% from $327M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Silverleafe Capital Partners deployed $13.9M of net new capital in Q4 2025, opening 15 new positions and adding to 38 existing holdings. Its largest new stake was Core Scientific: 72,950 shares worth $1.06M.

By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 8% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares Core Universal USD Bond ETF, an estimated $743K trimmed.

  • Silverleafe Capital Partners's largest Q4 2025 buy was Core Scientific: 72,950 shares worth $1.06M.
  • Silverleafe Capital Partners added most to Oklo in Q4 2025, an estimated $2.5M increase.
  • Silverleafe Capital Partners's biggest Q4 2025 reduction was iShares Core Universal USD Bond ETF, cutting an estimated $743K.
  • Silverleafe Capital Partners fully exited Bristol-Myers Squibb in Q4 2025, selling an estimated $916K.
  • Silverleafe Capital Partners's ten largest holdings make up 56% of its $337M portfolio in Q4 2025.
  • Silverleafe Capital Partners opened 15 new positions and closed 9 in Q4 2025.
  • Silverleafe Capital Partners's portfolio value rose 3.2% quarter-over-quarter to $337M.

Based on Silverleafe Capital Partners's 13F filing for Q4 2025, filed 12 Jan 2026.